Related Experiment Video

Updated: Jun 27, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Critical overview of clinical guidelines relating to invasive fungal infections

Márcio Borges Sá1, Rafael Zaragoza

  • 1Servicio de Medicina Intensiva, Hospital Son Llàtzer, Carretera de Manacor, Palma de Mallorca, Spain. mborges@hsll.es

International Journal of Antimicrobial Agents
|December 17, 2008
PubMed

Insights

Invasive fungal infections (IFIs) are increasing, necessitating updated guidelines. This review critically examines current IFIs guidelines, focusing on non-neutropenic critical patients.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Rising incidence of invasive fungal infections (IFIs) contributes to significant morbidity, mortality, and healthcare costs.
  • Recent advancements in diagnostics and antifungal therapies are reshaping IFI management.
  • Existing clinical guidelines for IFIs offer valuable recommendations but exhibit heterogeneity and potential bias.

Purpose of the Study:

  • To provide a critical overview of the role and limitations of current guidelines for managing invasive fungal infections.
  • To emphasize the specific challenges and considerations for IFIs in non-neutropenic critical patients.

Main Methods:

  • Critical review of existing literature on invasive fungal infections.
  • Analysis of current clinical guidelines for IFI diagnosis and treatment.
  • Focus on evidence-based recommendations versus expert opinion.

Main Results:

  • The landscape of IFI diagnosis and treatment is rapidly evolving with new tools and therapies.
  • Heterogeneity in guideline development and recommendations may stem from varying evidence interpretation and expert opinions.
  • A critical appraisal of guidelines is essential for optimizing IFI care, particularly in complex patient populations.

Conclusions:

  • Current guidelines for invasive fungal infections require critical evaluation due to variability in their development and recommendations.
  • Further research and consensus are needed to standardize IFI management, especially for non-neutropenic critical patients.
  • A nuanced approach to guideline application is crucial for effective IFI treatment in critical care settings.

More Related Videos

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...